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Abstract
In lieu of an abstract, below is the first paragraph of the paper.
The immune system of the human body serves as both an enemy and an ally. It is an ally when it constantly
fights off attacks from several types of microbes. However, it is an enemy when it attacks a life-saving heart
transplant or mistakenly eats away the tissues of the body (Marx, 1990). It is the job of the immune system to
keep the body healthy and free of harmful substances. Researchers have been aiming for ways to suppress
certain parts of the immune system while not interfering with the entire defenses of the body. By analyzing
how the immune system works researchers can gain a better understanding on what might help them succeed
in this process ( Janeway & Travers, 2006).
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The immune system of the human body 
serves as both an enemy and an ally. It is an ally 
when it constantly fights off attacks from several 
types of microbes. However, it is an enemy when it 
attacks a life-saving heart transplant or mistakenly 
eats away the tissues of the body (Marx, 1990). It is 
the job of the immune system to keep the body 
healthy and free of harmful substances. Researchers 
have been aiming for ways to suppress certain parts 
of the immune system while not interfering with the 
entire defenses of the body. By analyzing how the 
immune system works researchers can gain a better 
understanding on what might help them succeed in 
this process (Janeway & Travers, 2006). 
The immune system serves a very 
significant role in the human body. The body is 
persistently invaded with substances that can cause 
harm such as toxins, fungi, bacteria, parasites and 
viruses. If any of these microbes entered the body 
and were left untouched the body would become 
damaged. It is the role of the immune system to act 
as an army and to defend against the constant 
stream of foreign invaders. The immune system is 
the key element in retaining the overall health of the 
body and resistance to disease (Janeway & Travers, 
2006). 
The immune system is organized into innate 
and adaptive components. The innate system serves 
as the first line of defense. The innate system uses 
nonspecific cells such as phagocytic cells to interact 
with the microbe and protect the host. Natural killer 
cells are important in the innate response because 
they can lyse virally infected cells. Interferons also 
work in the innate response by inhibiting the 
replication of viruses (Nairn & Helbert, 2007). If the 
invading microbes become too numerous and the 
innate system is overwhelmed, the adaptive system 
is triggered. This system has the capability to 
distinguish self from nonself. However, the adaptive 
system does not happen as rapidly as the innate 
system does. The adaptive system takes many days 
to mobilize. The fact that each lymphocyte 
expresses a unique antigen receptor is critical to 
understanding the adaptive system. When an 
antigen comes in contact with a lymphocyte 
containing the receptor that fits with the particular 
antigen, the pre-existing cells divide and produce 
genetically identical daughter cells. This results in an 
increased availability of receptors specific for a 
particular antigen (Nairn & Helbert, 2007). The 
adaptive immune system is categorized by three 
major features. The first feature is specificity. The 
immune system is described as specific because it 
discriminates among a variety of molecular entities. 
The adaptive system is diverse because it has the 
ability to respond to various antigens that it 
encounters. Lastly, the adaptive system is 
characterized by having a memory. The adaptive 
system can remember previous antigens that 
infected a particular area and therefore increase the 
strength of response when infected again. This 
mechanism is referred to as immunological memory. 
Immunological memory adds to the overall strength 
of immunity of the body (Kamradt & Mitchision, 
2001). 
The state of having adequate biological 
responses to microbes is known as immunity 
(Kamradt & Mitchinson, 2001). Immunity has three 
further divisions known as active/adaptive 
immunity, innate and passive immunity. The 
individual plays a direct role in response to an 
antigen in active immunity. This type of immunity 
develops as children and adults experience different 
types of invaders throughout their lifetime. Also, 
active immunity is protective immunity that results 
after exposure to an infection or a vaccination. 
Lymphocytes play a major role in active immunity 
(Kamradt & Mitchinson, 2001). Lymphocytes are 
cells that are involved in the recognizing of previous 
invaders and destroying them. These cells originate 
in bone marrow and either remain there or further 
mature into B cells. They can also migrate to the 
thymus gland and mature into T cells. B 
lymphocytes serve as the military intelligence 
system. B cells watch for the targets and then 
construct a plan to capture their targets. T cells are 
the soldiers, using the intelligence system that the B 
cells have previously created to destroy the invader. 
In general, the structure of lymphocytes remains 
similar throughout the different types. Lymphocytes 
are usually small, and most of the DNA and protein is 
located inside the nucleus. Receptors are located on 
the surface of lymphocytes. Each receptor is specific 
for a particular antigen. Lymphocytes travel through 
the bloodstream and peripheral lymphoid organs. 
The three main types of peripheral lymphoid organs 
are the spleen, lymph nodes, and the gut-associated 
lymphoid tissue. The spleen serves the role of 
collection of the antigens from the bloodstream. 
The lymph nodes collect antigens from the tissues at 
cites of infection and the gut-associated lymphoid 
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tissue collects the antigens from the gut. These 
components of the immune system are essential to 
proper functioning (Janeway & Travers, 1996). 
The second type of immunity, passive 
immunity, involves the transferring of responses 
from one individual to another. The immune cells 
from an immunized individual get passed to an 
unimmunized individual. The anti-rabies shot is an 
example of passive immunity. After a dog bite, the 
victim is treated with anti-bodies to the rabies virus; 
however they have been produced by individuals 
other than the victim. Another example of passive 
immunity is the antibodies in the breast milk of 
mothers, which provide temporary protection for 
the infant. The final type of immunity, innate 
immunity, includes the external barriers of the body. 
The external barriers of the body are technically the 
first line of defense in preventing disease (Nairn & 
Helbert, 2007). The degree of immunity regulates 
the types of immune responses needed to keep the 
body healthy. 
The immune system is the driver behind 
immune responses. Immune responses are 
integrated bodily reactions to antigens. The immune 
system uses a series of steps to trigger immune 
responses which will attack the organisms and 
substances that invade the human body and aim to 
cause disease. Immune responses are the way in 
which the body recognizes and defends itself against 
the bacteria, viruses, and other material that may 
appear harmful to the body (Nairn & Helbert, 2007). 
Foreign substances that invade the body 
are known as antigens. When the body detects that 
an antigen has entered, many cells work together in 
the recognition of the antigen and a response to 
defeat the antigen. These cells immediately trigger 
the B cells which start to produce antibodies. 
Antibodies are specialized proteins that lock onto 
specific antigen receptors. These antibodies remain 
in the body even after the invader is destroyed. This 
is an advantage because if the invader returns into 
the body, the antibodies will already be present and 
immediately destroy the foreign substance. 
Antibodies can not work single-handedly on this 
task. Once they have bound to the receptor on the 
antigen the T cells destroy the antigen that has been 
tagged with antibodies (Marx, 1990). These antigens 
are the substances that trigger an active immune 
response. 
An active immune response involves a 
series of steps initiated by the immune system. The 
first phase is the cognitive phase in which the 
particular antigen is recognized. When the antigen 
reaches a cell containing the particular receptor the 
cell becomes activated and proliferation occurs. As 
more clones of the same cells are produced the next 
phase, activation, is triggered. During this phase the 
cells differentiate and enable a response. In turn, the 
antibodies try to eliminate the antigen in the 
effector phase. Once the antigen is fully eliminated 
a series of steps occur to regulate the response and 
more importantly inhibit the response from 
occurring once the antigen is neutralized (Nairn & 
Helbert, 2007). An active immune response is an 
involuntary action but does there lie a way to make 
an immune response voluntary? 
The regulation of immune responses is the 
major medical goal of research in the field of 
immunology. Researchers want to be able 
manipulate immune responses in way that would 
enable suppressing the response when it is 
unwanted and stimulating a response in such cases 
of prevention of infectious disease. Suppression of 
the immune system includes the topic of organ 
transplant. If there was a way to induce the immune 
system to tolerate a transplant the patient would no 
longer have to take immunosuppressants for the 
rest of his/her life. The implications of discovering a 
way to suppress the immune system could help with 
treatment of autoimmune diseases. The reason why 
this has not yet been discovered is because the 
immune system is very particular and sensitive. 
Manipulating with one part of the response can 
cause the whole immune system to react. Also 
specifically with organ transplants, there is no way to 
judge if tolerance has occurred unless the patient is 
taken off of the immunosuppressant drugs which 
provides an increased risk of rejection. 
Immunologists have discovered many techniques for 
inducing, measuring, and characterizing immune 
responses. (Janeway & Travers, 1996). Allergic 
reactions and organ rejections are two major areas 
of research dealing with suppression of the immune 
system. 
In the case of organ failure, transplantation 
has become the most common and efficient 
procedure to replace the organ. The main risk of 
organ transplantation is the rejection of the allograft 
by the host of the immune system. To avoid 
rejection of the transplant a variety of 
immunosuppressant drugs are used to target the 
adaptive T -cell response. Many of these same drugs 
are used to treat allergic reactions. It is therefore 
predicted that those patients using the 
immunosuppressant drugs should at no point while 
under therapy develop an allergic reaction to any 
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substance. The objective of this study was to 
evaluate in a cross-sectional design, the prevalence 
of immunoglobulin E-mediated sensitizations and 
type 1 allergy in solid-organ transplanted children 
and adolescents and to identify the risk factors 
(Dehlink, 2006). 
The participants came from the Medical 
University of Vienna between the years of 2004 and 
2005. In total there were seventy eight patients with 
kidney, lung or liver transplants used. The patients 
were treated with different combinations of 
steroids, proliferation inhibitors, kinases and 
phospatases inhibitors based on the individual 
patient. The medical charts of the patients were 
marked with the date of transplantation as well as 
the starting date of immunosuppressive therapy. To 
determine if there was a history of allergies in the 
patient or in the family, the patient was given an 
interview based on the International Study of 
Asthma and Allergies in Childhood criteria. The 
allergic sensitizations of each patient were examined 
by serum-lgE measurements and a skin prick test. 
The serum -IgE measurements were conducted by 
using a solid-phase immunoassay. The patients were 
tested for dust mite, cat and dog dander, cod fish, 
wheat flour, soy bean, peanuts, hazelnut, almond, 
coconut, rye, birch and other common allergens. 
Other sensitizations were tested if there was some 
other allergen present in the family determined in 
the survey. The total serum-lgE levels were 
converted into z units to account for the various 
differences in ages. The skin prick test was used to 
test a panel of allergens. To avoid interference with 
the skin prick test the patients were advised to stop 
using antihistamines for two weeks prior to the test. 
If there was further indication of specific allergens in 
the patient's history those were also done in the skin 
prick test. Each patient was classified as sensitized 
if they presented a positive skin prick test and had a 
reaction to at least one of the allergens or as allergic 
if they had additionally history of allergic diseases in 
the family (Dehlink, 2006). 
The data depict the prevalence of 
sensitization as well as the allergies among the 
patients. The sensitization refers to a positive result 
from the skin prick test or a specific IgE level greater 
than 0.35. 75.6% of the total number of patients had 
a negative result to the skin prick test while 24.4% 
had a positive sensitization. The majority of the 
positive skin prick results came from the kidney 
patients, but what also must be taken into account is 
that the greatest numbers of patients were kidney 
recipients. The next highest percentage were of 
sensitization followed by the lung recipients. The 
same order from greatest to least, kidney, liver, lung 
was displayed for the negative skin prick results. The 
data display the prevalence of allergy in the patients. 
89.7% of all patients had no allergy, defined in this 
study as a sensitization and additional history of 
allergic disease. 10.3% were defined as having the 
prevalence of allergies (Dehlink, 2006). 
The results of this study were surprising. 
The population of patients consisted of 50 kidney 
transplant patients, 19 liver transplant patients, and 
9 lung transplant patients. All of the patients did 
take part in the interview and serum IgE-
measurements. However, there were 20 allograft 
recipients that refused to take a skin prick test. Out 
of the total population of 78 patients, 19 were 
discovered to be sensitized to allergens and 16 
patients of those 19 patients displayed particular 
serum IgE. Also 13 of the 19 had a positive skin prick 
test to at least 1 allergen. Only 8 participants of the 
total population were designated as "allergic" 
because they reported a clinical history to type 1 
atopic diseases. The prevalence of sensitization and 
allergy was similar among all three types of 
transplant patients although between the subgroups 
the spectrum of sensitizations was different. Both 
kidney and liver recipients were sensitive to nutritive 
and inhalant allergies while the lung recipients were 
solely sensitive to inhalant allergies. The sensitized 
patients did not differ too much of an extent from 
the nonsensitized patients in regards to gender, age, 
date of transplant, history of allergies, or time of 
immunosuppressive medicine. No major differences 
were found when analyzing the various types of 
immunosuppressants or duration of the treatment 
(Dehlink, 2006). 
These results show that regardless of the 
immunosuppressive treatment, the organ transplant 
patients still can acquire certain sensitizations to 
inhalant or food allergies. The immunosuppressive 
treatment does not prevent allergic reactions. The 
most common symptoms of the allergies were 
seasonal rhinitis and rhinoconjuctivitis. No 
immunosuppressive drug was proven to be 
associated with the occurrence of allergies. There 
was no correlation between the transplanted organ 
and the prevalence of allergy because sensitization 
and allergy were equally distributed. It was 
demonstrated that the long-term 
immunosuppressive therapy does not have an effect 
on allergies in transplant patients. One suggestion 
for these results could be that the allergy had 
already existed before the organ allograft took place. 
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In this case the immunosuppressive drugs would not 
be able to control the allergen. The allergy may also 
develop within the time period of therapy and the 
immunosuppressive drugs do not recognize it as a 
foreign substance. In many cases of developing an 
allergy during post transplantation drug treatment 
the calcineurin inhibitor tacrolimus seemed to be the 
cause. This suggests that the immunologic 
mechanism behind this could be a suppression of the 
T-helper cells (Dehlink,2006). The presence of the 
allergen before the therapy was started is a 
possibility but there must be a underlying cause. 
Perhaps the allergen was present but not active 
inside the body, the immunosuppressant drugs 
triggered the allergen and therefore the symptoms 
of an allergic reaction appeared. An allergic reaction 
is a response from the immune system. 
The immune system releases a response to 
antigens that trigger certain allergic reactions. An 
allergy or atopy is an immediate hypersensitivity to 
reaction to environmental antigens, mediated by 
immunoglobin E (IgE). Allergies are very rapid 
reactions and the symptoms of a reaction occur 
within minutes of exposure to the particular antigen. 
The specific antigens that trigger the allergic 
reactions are called allergens. Allergens find a way 
into the body either by inhalation, becoming 
ingested, or injecting directly into the skin. 
Treatment of allergies is simply identification of the 
particular allergen that is causing the allergy and 
avoidance of those harmful allergens (Nairin & 
Helbert, 2007). 
Mast cells and eosinophils are the cells 
involved in allergies. Mast cells are resident in a 
wide number of tissues, whereas eosinophils 
migrate into tissues where type I hypersensitivity is 
taking place (Nairin & Helbert, 2007). These 
eosinophils release the mediators that cause the 
reaction to the allergen. After the specific allergen 
and IgE have come in contact with each other the 
mast cells initiate the symptoms of an allergic 
reaction. The production of IgE is essential for 
hypersensitivity reactions. Once the B cells are 
stimulated by interleukin-4 and T-helper 2 cells, the 
production of IgE begins. IgE then binds to FccRI 
which is located on the mast cells in tissue and 
eosinophils that have been activated. This is why 
when investigating the cause of the allergic reaction 
the IgE levels can be tested and used to help find the 
answer (Ling, 2004). 
To determine whether the amount of 
inhibition of allergic responses by CD4 + CD25 + T 
cells was related to allergic disease CD4 was used. 
CD4 is a marker of the helper T cell subset that 
interacts with B lymphocytes in induce 
immunoglobulin production or activate other 
immune cells via cytokines (Ling, 2004). Cytokines 
are small proteins produced by T cells that act as 
signals to other cells of the immune system or 
structural cells. CD25 is the chain of the receptor for 
interleukin 2. T cells are cells that control immune 
responses by recognition of specific sequences from 
foreign molecules presented by MHCs on antigen 
presenting cells. The correlation between activity of 
regulatory T cells and disease in humans was 
investigated. Analysis of the mechanism involved in 
suppression of allergen- induced T cells was also 
conducted (Ling, 2004). 
The participants in this study were 
volunteers. Patients with seasonal allergies to grass 
pollen were from an allergy clinic. Atopic donors 
had positive IgE skin test and a history of allergic 
symptoms. The non-atopic donors had negative skin 
prick tests and no history of allergic symptoms in the 
past. The seasonal allergy donors had positive skins 
test to grass pollen but to no other allergens. The 
first part of the procedure involved cell separation. 
Blood samples were obtained and basic cell culture 
with the allergen extract was performed. The PBMC 
of the allergen was separated using density 
centrifugation. The CD4 + T cells were isolated by 
negative selection and the CD5 + T cells were 
isolated using positive selection. The CD4 + cells 
were enriched to a median of 96% while the CD25 + 
cells were enriched to a median of 82%. The cells 
were cultured in well plates with allergen extracts. 
Autologous irradiated mononuclear cells were added 
as antigen presenting cells to all cultures. The 
cultures contained the following: PBMC's, CD4 + 
CD25+ cells alone, CD4+ CD25- cells alone, CD4+ 
CD25- and CD4+ CD25+ T cells at a ratio of two to 
one to control for the amplified cell density of the 
CD25 + CD25- cultures. Supernatant was added for 
cytokine analysis with the Luminex bead system. H-
thymidine was also added to the culture. After the 
cells were harvested, counting of incorporated 
radioactivity as index of proliferation occurred. 
(Ling, 2004). 
CD4+ CD25, CD4+ CD25- T cells, or mixed 
CD4+ CD25 + and CD4 + CD25- cells in a were 
cultured in order to compare the regulation of non-
allergen driven cultures between atopic and non-
atopic donors. A cat allergen reactive Th-2 clone 
was generated from an atopic donor by using 
limiting dilution. This clone produced interleukin 5 
and interleukin 13. A cat allergen peptide reactive 
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ThO clone was generated from a non-atopic donor. 
This clone produced interleukin 2, interleukin 5, and 
interleukin 13. The clones were combined in a 
mixing experiment with CD4+ CD25+ Tcells. The cells 
were cultured. Blocking antibodies were added. 
Flow cytometry was conducted on CD4+CD25 - T 
cells. RNA was extracted from CD4+ CD25 + and 
CD4+ CD25- cell pellets with a kit. RNA was 
quantified and then underwent reverse 
transcription. PCR procedures in triplicate sequence 
detection system were performed. (Ling, 2004). 
The data represent the mechanisms of 
suppression. The data display the proliferation of a 
Th2 cell clone by CD4+CD25+ T cells from an atopic 
donor. The proliferation is recorded in units of cpm 
for three separate experiments. The first, CD4+25+, 
shows a proliferation value of 0 cpm. The second 
experiment shows the T cell clone which had a 
proliferation value of approximately 67,000cpm. 
The third experiment is the T cell clone with CD4+ 25 
+. The proliferation value for this experiment was 
approximately 10,000cpm. The data show the 
allergen-induced T cell proliferation and cytokine 
production by CD4+CD25+ T cells with and without 
the presence of the antibody to glucocortitoid-
induced tumor necrosis factor receptor. The data 
reveal the information from one donor which 
represents three different experiments. This data 
came from a non-atopic donor. The data display the 
control antibody and the antibody glucocortitoid-
induced tumor necrosis factor receptor for CD4+25+, 
CD4+25-, and CD4+25-CD4+25+. The proliferation in 
order from least to greatest is as follows: CD4+25+ 
CD4+25-CD4+25+ and CD4+25. (Ling, 2004). 
The CD4+ CD25 + T cells from non-atopic 
donors showed little or no proliferation at all when 
stimulated by allergens. The culture of CD4+ CD25-
T cells with allergen showed a substantial amount of 
proliferation as well as production of interleukin 5. 
The non-atopic individuals with asymptomatic and 
symptomatic atopic allergic patients were 
compared. The percentage suppression of allergen 
driven proliferation of CD25- T cells by CD25+ T cells 
was substantially reduced when the cells of the 
atopic donor was compared with cells from the non-
atopic patients. The suppression of interleukin 5 by 
CD4+ CD 25 + T cells in cultures of asymptomatic 
donors did not differ significantly from the non-
atopic volunteers. In the patients with seasonal 
allergies CD4+CD25+ Tcell inhibition of grass pollen 
and allergen stimulated proliferation and production 
of interleukin 5 was lower than the non- atopic and 
atopic patients. Suppression of proliferation was of 
course greater when the individuals were studied 
out of season. No difference was discovered in the 
proportion of CD4+ cells positive for CD25+ between 
groups or in expression of CD69 or intracellular CTLA 
4 on regulatory T cells than the activated T cells. To 
test capability of suppression of the T cells, allergen 
specific T cell clones were obtained. It was displayed 
that CD4+CD25 T cells suppressed proliferation of 
the Th2 clone from the atopic donor. The CD4+CD25 
T cells inhibited proliferation of a peptide-specific 
ThO clone from the same nonatopic donor. The 
antibody to glucocorticoid-induced tumor necrosis 
factor receptor reversed cell suppression but the 
antibodies against this receptor did not reverse 
inhibition of interleukin 5, 13, or y production (Ling, 
2004). 
The suppression of CD4+ CD25 + T cells 
relates to the existence of clinical allergies has been 
demonstrated. This is due to the fact that the 
inhibition of the allergen-driven responses by cells 
from atopic donors was less than the non-atopic 
donors and the least by those cells isolated from the 
patients with seasonal allergies. Both the atopic-and 
nonatopic donors showed growth of PBMC's to 
allergens in the culture. However, they showed 
differing results in the production of Th2 cytokines. 
This study demonstrated that T cells can suppress 
allergen-driven proliferation as well as cytokine 
production (Ling, 2004). 
The major result of this study is that as T 
ceil activation is reduced in atopic versus nonatopic 
individuals and reduced even greater when exposure 
to an allergen is observed suggests many 
possibilities. The data suggest that there may be a 
deficiency in the regulation of CD25+ T cells in the 
atopic donors. Another possibility is the dilution of 
regulatory CD25+ T cells during allergen exposure. 
Another suggestion is that when exposed to an 
allergen the effector T cells are activated in a way 
that they do not respond to signals from the CD4+ 
CD25+ T cells. Those patients with hay fever had a 
reduced ability of the T cells to suppress allergen 
responses. This suggests that perhaps their CD25-
cells had been activated by certain mechanisms and 
therefore was not responsive to regulation. The 
data collected in this study suggests several reasons 
why some children develop allergies while others do 
not. The first reason could be an absence of Thl 
responses which deal with infection. A deficiency in 
the maturation of the T cells could exist and this 
would therefore lead to unchecked Th2 responses. 
In atopic sensitization, there is a defect in the 
regulation of Th2 responses to T cells. The study 
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suggests that CD4+ CD25 + T cells can prevent the 
activation of certain Th2 responses in non-atopic 
donors. Failure of such suppression could result in 
allergic disease. This implies that certain T-cell 
mediated diseases are results of an imbalance 
between inhibition and activation of T cells (Ling, 
2004). The data suggest that by dissecting a 
particular pathway of the immune system the 
possibility of therapy on the pathway exists. 
The future in immunology looks impressvie, 
specific suppression of immune responses is in sight. 
Scientists have recently discovered how to grow cells 
that suppress immune responses. Scientists have 
found a way to grow T- regulatory cells type 1. 
These cells are predicted to be the key to turning off 
unwanted immune reactions. These cells could even 
inhibit the action of certain immune cells that if not 
blocked would attack the body. This discovery could 
help with the developments of new treatments and 
therapies for many autoimmune diseases. It could 
also provide scientists with a better understanding 
of infectious diseases and could help in organ 
rejection after transplantation. Using this technique, 
scientists can now take a blood sample from a 
patients arm ad culture the cells. A few days later 
the cultured cells will be t-regulatory cells. The hope 
of researchers is to continue studying the factors 
involved in the differentiation and function of the T 
regulatory cells type 1. Once these factors are 
identified manipulating the activity of the Trl cells 
for therapeutic use will be possible. Other 
colleagues found that the stimulation of CD46 and 
the T-cell receptors caused the growth of t 
lymphocytes which produced interleukin 10. This is 
also groundbreaking because interleukin 10 is the 
substance that suppresses the action and 
proliferation of immune cells (Kemper, 2003). 
The immune system is essential to the 
overall health of the body. If it was manipulated in a 
certain way to suppress unwanted responses but at 
the same time not lower the degree at which it 
protects the body, some diseases would no longer 
be existent. Allergies to a common environmental 
substance, rejection of a life saving organ, and 
maternal antibody that causes the fetus to become 
affected by erythroblastosis would all be gone 
(Rowley, 1973). The possibilities if suppression was 
discovered would be endless. In the future it may be 
beneficial to suppress the antibody response to a 
tumor. Perhaps an antibody to the tumor prevented 
immunologic injury to the tumor. Small 
manipulations and inhibition of immune responses 
has already occurred. The race was started more 
than 60 years ago and the finish line is in sight. 
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